Prem Watsa’s Meridian Bioscience Inc VIVO Stock Holding History

Prem Watsa’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-41,400	Closed	-$1.37M	–	75
2022 Q4	$1.37M	Buy	+41,400	New	+$1.33M	0.03%	42

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Prem Watsa's VIVO Position: Q1 2023 in Review

Prem Watsa sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 41,400 shares — an estimated $1.37M sold.

Prem Watsa first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $1.37M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Prem Watsa reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Prem Watsa sold 41,400 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.37M.
Prem Watsa first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Prem Watsa's Meridian Bioscience Inc position peaked at $1.37M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Fairfax Financial Holdings's 13F filing for Q1 2023, filed 15 May 2023.